ES2122015T3 - Uso de urodilatina en enfermedades pulmonares y bronquiales. - Google Patents
Uso de urodilatina en enfermedades pulmonares y bronquiales.Info
- Publication number
- ES2122015T3 ES2122015T3 ES93912706T ES93912706T ES2122015T3 ES 2122015 T3 ES2122015 T3 ES 2122015T3 ES 93912706 T ES93912706 T ES 93912706T ES 93912706 T ES93912706 T ES 93912706T ES 2122015 T3 ES2122015 T3 ES 2122015T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- urodilatine
- lung
- bronchial diseases
- date nov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000014181 Bronchial disease Diseases 0.000 title abstract 2
- 208000019693 Lung disease Diseases 0.000 title abstract 2
- 210000004072 lung Anatomy 0.000 title 1
- 108010001957 Ularitide Proteins 0.000 abstract 1
- 102400001279 Urodilatin Human genes 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- IUCCYQIEZNQWRS-DWWHXVEHSA-N ularitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 IUCCYQIEZNQWRS-DWWHXVEHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE UNA PREPARACION FARMACEUTICA, QUE CONTIENE URODILATINA COMO SUSTANCIA ACTIVA Y EVENTUALMENTE SUSTANCIAS ADICIONALES AUXILIARES DE RELLENO HABITUALES, PORTADORAS, O SUSTANCIAS DE DILUCION, PARA EL TRATAMIENTO DE ENFERMEDADES PULMONARES Y/O BRONQUIALES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4216133A DE4216133A1 (de) | 1992-05-15 | 1992-05-15 | Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2122015T3 true ES2122015T3 (es) | 1998-12-16 |
Family
ID=6458997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93912706T Expired - Lifetime ES2122015T3 (es) | 1992-05-15 | 1993-05-12 | Uso de urodilatina en enfermedades pulmonares y bronquiales. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5571789A (es) |
| EP (1) | EP0642349B1 (es) |
| JP (1) | JP3172188B2 (es) |
| AT (1) | ATE169225T1 (es) |
| CA (1) | CA2135614C (es) |
| DE (2) | DE4216133A1 (es) |
| ES (1) | ES2122015T3 (es) |
| WO (1) | WO1993023070A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995028952A1 (de) * | 1992-12-09 | 1995-11-02 | Haemopep Pharma Gmbh | Verwendung der brain natriuretic peptide (bnp), phosphoryliertes urodilatin, phosphoryliertes cdd/anp sowie deren kombinationen |
| US6232082B1 (en) | 1998-12-01 | 2001-05-15 | Nabi | Hapten-carrier conjugates for treating and preventing nicotine addiction |
| DE19942230C2 (de) * | 1999-09-03 | 2003-09-25 | Wolf-Georg Forssmann | Verwendung natriuretischer Peptide als antibiotisch wirksame Subsanzen zur Behandlung von bakteriellen Infektionen |
| DE19951471A1 (de) * | 1999-10-26 | 2001-05-03 | Forssmann Wolf Georg | Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen |
| EP2510942B1 (en) | 2005-04-07 | 2015-09-02 | Cardiorentis AG | Use of natriuretic peptide for treating heart failure |
| US20080181903A1 (en) * | 2006-12-21 | 2008-07-31 | Pdl Biopharma, Inc. | Conjugate of natriuretic peptide and antibody constant region |
| EP2185183B1 (en) * | 2007-09-11 | 2016-03-16 | Cardiopep Pharma GmbH | Use of natriuretic peptides for treating angioedema syndromes |
| WO2009040027A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of the peptide stresscopin as a therapeutic agent |
| EP2078530A1 (en) | 2008-01-08 | 2009-07-15 | Pharis Biotec GmbH | Use of natriuretic peptides for treating angioedema syndromes |
| WO2009086166A1 (en) * | 2007-12-19 | 2009-07-09 | Ekr Therapeutics, Inc. | Room temperature stable, lyophilized natriuretic peptide formulations |
| EP2898900B1 (en) | 2008-09-19 | 2017-11-15 | Nektar Therapeutics | Polymer conjugates of ziconotide |
| JP6097072B2 (ja) * | 2012-12-27 | 2017-03-15 | 日本航空電子工業株式会社 | コネクタ |
| JP2016505065A (ja) | 2013-01-25 | 2016-02-18 | カーディオレンティス リミテッド | 心血管症候の治療方法 |
| WO2016131943A1 (en) | 2015-02-20 | 2016-08-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of obesity and complications arising therefrom including type 2 diabetes |
| WO2022029499A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Methods of treating refractory ascites |
| WO2022029497A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Ularitide for use in methods of treating refractory ascites |
| CA3217598A1 (en) | 2021-05-06 | 2022-11-10 | Par Ingemar Johansson | Diagnosing and treating critically ill subjects |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614738B2 (en) * | 1987-03-02 | 1991-09-12 | Forssmann, Prof. Dr. Med Wolf-Georg | New cardiodilatin fragment, process for preparing same and use thereof |
| DE4117078A1 (de) * | 1991-05-25 | 1992-11-26 | Boehringer Ingelheim Kg | Verfahren zur herstellung therapeutisch anwendbarer aerosole |
-
1992
- 1992-05-15 DE DE4216133A patent/DE4216133A1/de not_active Withdrawn
-
1993
- 1993-05-12 ES ES93912706T patent/ES2122015T3/es not_active Expired - Lifetime
- 1993-05-12 AT AT93912706T patent/ATE169225T1/de not_active IP Right Cessation
- 1993-05-12 US US08/335,695 patent/US5571789A/en not_active Expired - Lifetime
- 1993-05-12 EP EP93912706A patent/EP0642349B1/de not_active Expired - Lifetime
- 1993-05-12 CA CA002135614A patent/CA2135614C/en not_active Expired - Lifetime
- 1993-05-12 WO PCT/EP1993/001189 patent/WO1993023070A1/de not_active Ceased
- 1993-05-12 JP JP51988493A patent/JP3172188B2/ja not_active Expired - Lifetime
- 1993-05-12 DE DE59308848T patent/DE59308848D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE4216133A1 (de) | 1993-11-18 |
| CA2135614A1 (en) | 1993-11-25 |
| JPH07508722A (ja) | 1995-09-28 |
| US5571789A (en) | 1996-11-05 |
| ATE169225T1 (de) | 1998-08-15 |
| JP3172188B2 (ja) | 2001-06-04 |
| DE59308848D1 (de) | 1998-09-10 |
| EP0642349A1 (de) | 1995-03-15 |
| WO1993023070A1 (de) | 1993-11-25 |
| CA2135614C (en) | 2009-04-28 |
| EP0642349B1 (de) | 1998-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59308848D1 (de) | Anwendung von urodilatin bei lungen- und bronchialerkrankungen | |
| UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
| ATE223230T1 (de) | Pulmonäre verabreichung des löslichen komplement- receptors typ 1 scr1 | |
| DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| YU59092A (sh) | Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja | |
| EA199901031A1 (ru) | Производные бензимидазола | |
| MY130157A (en) | Method of use for inhibiting bone loss and lowering serum cholesterol | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| KR950700333A (ko) | 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes) | |
| EP1153924A3 (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
| NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
| ATE242265T1 (de) | Auf papillomaviren basierende pharmazeutische präparate | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| DE69728914D1 (de) | Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen | |
| GB9424766D0 (en) | Pharmaceutical composition | |
| ATE184798T1 (de) | Hgh enthaltende pharmazeutische zubereitungen | |
| KR950700234A (ko) | β-페닐이소세린 및 그외 동족체를 제조하는 방법(Method for preparing β-phenylisoserine and analogues thereof) | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
| NO993407L (no) | Fremstilling av proteinpreparater med nedsatt aggregatinnhold | |
| RU96120655A (ru) | Композиция для профилактики и лечения гриппа и орви | |
| EE03876B1 (et) | Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid | |
| NO950177D0 (no) | Farmakologisk aktive erivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 642349 Country of ref document: ES |